抑制NADPH氧化酶阻断NETosis并减少肝素诱导血小板减少症中的血栓形成
肝素诱导血小板减少症(HIT)可伴严重血栓并发症,NETosis是HIT血栓形成的重要驱动因素。研究显示HIT免疫复合物激活中性粒细胞诱导ROS依赖性NETosis,血栓中血小板和中性粒细胞均产ROS且NETs与ROS遍布血凝块。抑制NOX2可阻断HIT诱导的NETosis和血栓形成,且不影响血小板减少。
要点
- HIT免疫复合物通过ROS依赖性途径诱导中性粒细胞NETosis。
- 抑制NOX2可阻断HIT诱导的NETosis和血栓形成,但不影响血小板减少。
- NOX2是HIT抗血栓治疗的潜在新靶点。
核心结论
- ROS和NOX2在HIT的NETosis和血栓形成中起关键作用,NOX2是HIT抗血栓治疗的潜在新靶点。
研究设计与样本
- 使用HIT免疫复合物激活中性粒细胞、微流体系统分析血栓、FcγRIIa+/hPF4+转基因小鼠体内实验及活动性HIT患者新鲜血液验证。
主要发现
- HIT免疫复合物诱导ROS依赖性NETosis。
- 微流体系统中血栓内血小板和中性粒细胞均产ROS,NETs和ROS遍布血凝块。
- 中性粒细胞靶向ROS抑制足以阻断人血中HIT诱导的NETosis和血栓形成。
- 用二苯基碘氯化物或GSK2795039抑制NOX2可消除FcγRIIa+/hPF4+转基因小鼠体内HIT诱导的血栓。
- ROS抑制不影响小鼠血小板减少,活动性HIT患者活化中性粒细胞ROS产生增加。
临床怎么用
- NOX2抑制可能作为HIT抗血栓治疗的新策略,且不影响血小板减少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Heparin-induced thrombocytopenia (HIT) is associated with severe and potentially lethal thrombotic complications. NETosis was recently shown to be an important driver of thrombosis in HIT. We investigated the role of reactive oxygen species (ROS) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 (NOX2) and their contributions to thrombus development in HIT. We showed that neutrophil activation by HIT immune complexes induced ROS-dependent NETosis. Analysis of thrombi formed in a microfluidics system showed ROS production in both platelets and neutrophils, and abundant neutrophil extracellular traps (NETs) and ROS distributed throughout the clot. Neutrophil-targeted ROS inhibition was sufficient to block HIT-induced NETosis and thrombosis using human blood. Inhibition of NOX2 with diphenyleneiodonium chloride or GSK2795039 abrogated HIT-induced thrombi in vivo using FcγRIIa+/hPF4+-transgenic mice. Thrombocytopenia in mice remained unaffected by ROS inhibition. Increased ROS production in activated neutrophils was also confirmed using fresh blood from patients with active HIT. Our findings show that ROS and NOX2 play a crucial role in NETosis and thrombosis in HIT. This enhances our understanding of the processes driving thrombosis in HIT and identifies NOX2 as a potential new therapeutic target for antithrombotic treatment of HIT.
引用
- Leung HHL, Perdomo J, Ahmadi Z, et al. Inhibition of NADPH oxidase blocks NETosis and reduces thrombosis in heparin-induced thrombocytopenia. Blood Adv. 2021. PMID: 34478504. doi:10.1182/bloodadvances.2020003093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。